Sommaire

Numéro précédent | Numéro suivant

• • ·Table of Contents

    Page :A1

    
• • ·Editorial Board

    Page :A4

    
• • ·Information for Readers

    Page :A5

    

• Results of Expert Meetings

  • ·Unique device identifiers for coronary stent postmarket surveillance and research: A report from the Food and Drug Administration Medical Device Epidemiology Network Unique Device Identifier Demonstration

    Page :405

    James E. Tcheng, Jay Crowley, Madris Tomes, Terrie L. Reed, Joseph M. Dudas, Kweli P. Thompson, Kirk N. Garratt, Joseph P. Drozda, MDEpiNet UDI Demonstration Expert Workgroup

    Résumé Résumé Plan Plan  

• Curriculum in Cardiology

  • ·Transcatheter aortic valve replacement: Historical perspectives, current evidence, and future directions

    Page :414-423

    Aaron Horne, Elizabeth A. Reineck, Rani K. Hasan, Jon R. Resar, Matthews Chacko

    Résumé Résumé Plan Plan  

• Trial Designs

  • ·Design and rationale of the ANALYZE ST study: A prospective, nonrandomized, multicenter ST monitoring study to detect acute coronary syndrome events in implantable cardioverter-defibrillator patients

    Page :424

    C. Michael Gibson, Mitchell Krucoff, Ajay J. Kirtane, Sunil V. Rao, Judith A. Mackall, Ray Matthews, Samir Saba, Ron Waksman, David Holmes

    Résumé Résumé Plan Plan
  • ·Rationale and design of the MONITOR-ICD study: A randomized comparison of economic and clinical effects of automatic remote MONITORing versus control in patients with mplantable ardioverter efibrillators

    Page :430-437

    Markus Zabel, Falk Müller-Riemenschneider, J. Christoph Geller, Johannes Brachmann, Volker Kühlkamp, Rüdiger Dissmann, Thomas Reinhold, Stephanie Roll, Lars Lüthje, Frank Bode, Lars Eckardt, Stefan N. Willich, MONITOR-ICD investigators

    Résumé Résumé Plan Plan  
  • ·Finding atrial fibrillation in stroke patients: Randomized evaluation of enhanced and prolonged Holter monitoring—Find-AF_RANDOMISED —rationale and design

    Page :438

    Mark Weber-Krüger, Götz Gelbrich, Raoul Stahrenberg, Jan Liman, Pawel Kermer, Gerhard F. Hamann, Joachim Seegers, Klaus Gröschel, Rolf Wachter, Find-AFRANDOMISED investigators

    Résumé Résumé Plan Plan  
  • ·The effect of indapamide versus hydrochlorothiazide on ventricular and arterial function in patients with hypertension and diabetes: Results of a randomized trial

    Page :446-456

    Dragos Vinereanu, Raluca Dulgheru, Stefania Magda, Ruxandra Dragoi Galrinho, Maria Florescu, Mircea Cinteza, Christopher Granger, Andrea O. Ciobanu

    Résumé Résumé Plan Plan  

• Clinical Investigations

  • ·Effectiveness of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina according to baseline hemoglobin A_1c

    Page :457

    Suzanne V. Arnold, Darren K. McGuire, John A. Spertus, Yan Li, Patrick Yue, Ori Ben-Yehuda, Luiz Belardinelli, Philip G. Jones, Ann Olmsted, Bernard R. Chaitman, Mikhail Kosiborod

    Résumé Résumé Plan Plan  
  • ·Prevalence of glucose abnormalities among patients presenting with an acute myocardial infarction

    Page :466

    Suzanne V. Arnold, Kasia J. Lipska, Yan Li, Darren K. McGuire, Abhinav Goyal, John A. Spertus, Mikhail Kosiborod

    Résumé Résumé Plan Plan  
  • ·Clinical outcomes of hybrid coronary revascularization versus coronary artery bypass surgery in patients with diabetes mellitus

    Page :471-478

    Ralf E. Harskamp, Patrick F. Walker, John H. Alexander, Ying Xian, Henry A. Liberman, Robbert J. de Winter, Thomas A. Vassiliades, Eric D. Peterson, John D. Puskas, Michael E. Halkos

    Résumé Résumé Plan Plan  
  • ·Dual antiplatelet therapy in patients with stable coronary artery disease in modern practice: Prevalence, correlates, and impact on prognosis (from the Suivi d’une cohorte de patients COROnariens stables en region NORd-Pas-de-Calais study)

    Page :479-486

    Gilles Lemesle, Nicolas Lamblin, Thibaud Meurice, Olivier Tricot, Robert Lallemant, Olivier Nugue, Maxence Delomez, Octave Equine, Sylvie Tondeux, Christophe Bauters

    Résumé Résumé Plan Plan  
  • ·Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)

    Page :487-494

    Emily C. O’Brien, DaJuanicia N. Simon, Larry A. Allen, Daniel E. Singer, Gregg C. Fonarow, Peter R. Kowey, Laine E. Thomas, Michael D. Ezekowitz, Kenneth W. Mahaffey, Paul Chang, Jonathan P. Piccini, Eric D. Peterson

    Résumé Résumé Plan Plan  
  • ·PA32540 (a coordinated-delivery tablet of enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg) versus enteric-coated aspirin 325 mg alone in subjects at risk for aspirin-associated gastric ulcers: Results of two 6-month, phase 3 studies

    Page :495

    David J. Whellan, Jay L. Goldstein, Byron L. Cryer, Glenn M. Eisen, Angel Lanas, Alan B. Miller, James M. Scheiman, John G. Fort, Ying Zhang, Christopher O’Connor

    Résumé Résumé Plan Plan  
  • ·Prognostic implications of creatine kinase–MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention

    Page :503

    Akshay Bagai, Phillip J. Schulte, Christopher B. Granger, Kenneth W. Mahaffey, Robert H. Christenson, Gregory Bell, Renato D. Lopes, Cynthia L. Green, A. Michael Lincoff, Paul W. Armstrong, Matthew T. Roe

    Résumé Résumé Plan Plan  
  • ·Cardioprotective role of ischemic postconditioning in acute myocardial infarction: A systematic review and meta-analysis

    Page :512

    Abdur Rahman Khan, Aref A. Binabdulhak, Yaseen Alastal, Sobia Khan, Bridget M. Faricy-Beredo, Faraz Khan Luni, Wade M. Lee, Sadik Khuder, Jodi Tinkel

    Résumé Résumé Plan Plan  
  • ·Impact of an invasive strategy on 5 years outcome in men and women with non–ST-segment elevation acute coronary syndromes

    Page :522-529

    Joakim Alfredsson, Tim Clayton, Peter Damman, Keith A.A. Fox, Mats Fredriksson, Bo Lagerqvist, Lars Wallentin, Robbert J. de Winter, Eva Swahn

    Résumé Résumé Plan Plan  
  • ·Platelet reactivity during ticagrelor maintenance therapy: A patient-level data meta-analysis

    Page :530-536

    Dimitrios Alexopoulos, Ioanna Xanthopoulou, Robert F. Storey, Kevin P. Bliden, Udaya S. Tantry, Dominick J. Angiolillo, Paul A. Gurbel

    Résumé Résumé Plan Plan  
  • ·Safety of coronary angiography and percutaneous coronary intervention via the radial versus femoral route in patients on uninterrupted oral anticoagulation with warfarin

    Page :537-544

    Nevin C. Baker, Erik W. O'Connell, Wah Wah Htun, Haiyan Sun, Sandy M. Green, Kimberly A. Skelding, James C. Blankenship, Thomas D. Scott, Peter B. Berger

    Résumé Résumé Plan Plan
  • ·Does baseline hematocrit influence the assays of on-treatment platelet reactivity to clopidogrel?

    Page :545-551

    Lakshmana K. Pendyala, Joshua P. Loh, Thibault Lhermusier, Sa’ar Minha, Marco A. Magalhaes, Rebecca Torguson, Fang Chen, Lowell F. Satler, Augusto D. Pichard, Ron Waksman

    Résumé Résumé Plan Plan  
  • ·Differences in sex-related bleeding and outcomes after percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) registry

    Page :552-559

    Hussein Othman, Sherezade Khambatta, Milan Seth, Thomas A. Lalonde, Howard S. Rosman, Hitinder S. Gurm, Rajendra H. Mehta

    Résumé Résumé Plan Plan  
  • ·Mortality after presentation with stent thrombosis is associated with time from index percutaneous coronary intervention: A report from the VA CART program

    Page :560-567

    Ehrin J. Armstrong, Thomas M. Maddox, Evan P. Carey, Gary K. Grunwald, Kendrick A. Shunk

    Résumé Résumé Plan Plan  
  • ·Development of a data set of national cardiovascular deaths in the young

    Page :568

    Victoria L. Vetter, Noreen P. Dugan, Danielle Main Haley, Theresa M. Covington, Heather Dykstra, Mary Overpeck, V. Ramesh Iyer, Justine Shults

    Résumé Résumé Plan Plan  
  • ·The impact of prolonged lower limb ischemia on amputation, mortality, and functional status: The FRIENDS registry

    Page :577-587

    Sue Duval, Hong H. Keo, Niki C. Oldenburg, Iris Baumgartner, Michael R. Jaff, James M. Peacock, Alexander S. Tretinyak, Timothy D. Henry, Russell V. Luepker, Alan T. Hirsch

    Résumé Résumé Plan Plan  
  • ·Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: Insights from Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER)

    Page :588-596

    William Schuyler Jones, Pierluigi Tricoci, Zhen Huang, David J. Moliterno, Robert A. Harrington, Peter R. Sinnaeve, John Strony, Frans Van de Werf, Harvey D. White, Claes Held, Paul W. Armstrong, Philip E. Aylward, Edmond Chen, Manesh R. Patel, Kenneth W. Mahaffey

    Résumé Résumé Plan Plan  
  • ·Physical activity and resting pulse rate in older adults: Findings from a randomized controlled trial

    Page :597-604

    Bríain O’Hartaigh, Marco Pahor, Thomas W. Buford, John A. Dodson, Daniel E. Forman, Thomas M. Gill, LIFE Study Group

    Résumé Résumé Plan Plan  

• Erratum

  • ·Correction

    Page :605

    

• Letters to the Editor

  • ·The fibrosis biomarkers procollagen type III, N-terminal propeptide and transforming growth factor ?1 as foes for patients with atrial fibrillation

    Page :e15

    Hui Tao, Wei Cao, Kai-Hu Shi

    
  • ·Letter to the editor regarding manuscript “Resuscitation Outcomes Consortium–Amiodarone, Lidocaine or Placebo: Rationale and methodology behind out-of-hospital cardiac arrest antiarrhythmic drug trial”

    Page :e17

    Primiano Iannone

    
  • ·Regarding manuscript: “Resuscitation Outcomes Consortium–Amiodarone, Lidocaine, or Placebo study: Rationale and methodology behind out-of-hospital cardiac arrest antiarrhythmic drug trial”

    Page :e19

    Peter J. Kudenchuk, Siobhan P. Brown, Mohamud Daya, Laurie J. Morrison, Judy Powell, Brian Leroux, Paul Dorian